- Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's oncology group study on behalf of the Dutch Childhood Oncology Group and the German Cooperative Study Group for childhood acute lymphoblastic leukemia
[作者:Bhojwani, D; Kang, H; Menezes, RX; Yang, W; Sather, H; Moskowitz, NP; Min, DJ; Potter, JW; Harvey, R; Hunger, SP; Seibel, N; Raetz, EA; Pieters, R; Horstmann, MA; Relling, MV; den Boer, ML; Willman, CL; Carroll, WL,期刊:Journal of clinical oncology, 页码:4376-4384 , 文章类型: Article,,卷期:2008年26-27]
- PurposeTo identify children with acute lymphoblastic leukemia (ALL) at initial diagnosis who are at risk for inferior response to therapy by using molecular signatures.Patients and MethodsGene expression profiles were ge...
- Medical care in long-term survivors of childhood cancer: A report from the Childhood Cancer Survivor Study
[作者:Nathan, PC; Greenberg, ML; Ness, KK; Hudson, MM; Mertens, AC; Mahoney, MC; Gurney, JG; Donaldson, SS; Leisenring, WM; Robison, LL; Oeffinger, KC,期刊:Journal of clinical oncology, 页码:4401-4409 , 文章类型: Article,,卷期:2008年26-27]
- PurposeTo evaluate whether childhood cancer survivors receive regular medical care focused on the specific morbidities that can arise from their therapy.Patients and MethodsWe conducted a cross-sectional survey of health...
- Results of the EICESS-92 study: Two randomized trials of Ewing's sarcoma treatment - Cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients
[作者:Paulussen, M; Craft, AW; Lewis, I; Hackshaw, A; Douglas, C; Dunst, J; Schuck, A; Winkelmann, W; Kohler, G; Poremba, C; Zoubek, A; Ladenstein, R; van den Berg, H; Hunold, A; Cassoni, A; Spooner, D; Grimer, R; Whelan, J; McTiernan, A; Jurgens, H,期刊:Journal of clinical oncology, 页码:4385-4393 , 文章类型: Article,,卷期:2008年26-27]
- PurposeThe European Intergroup Cooperative Ewing's Sarcoma Study investigated whether cyclophosphamide has a similar efficacy as ifosfamide in standard-risk (SR) patients and whether the addition of etoposide improves su...
- Phase I study of weekly oxaliplatin in relapsed or refractory pediatric solid malignancies
[作者:Geoerger, B; Doz, F; Gentet, JC; Mayer, M; Landman-Parker, J; Pichon, F; Chastagner, P; Rubie, H; Frappaz, D; Le Bouil, A; Gupta, S; Vassal, G,期刊:Journal of clinical oncology, 页码:4394-4400 , 文章类型: Article,,卷期:2008年26-27]
- PurposeTo explore feasibility, maximum-tolerated dose (MTD), and recommended dose (RD) for phase II studies of weekly oxaliplatin for the treatment of relapsed or refractory pediatric solid malignancies.Patients and Meth...
- Gene expression signatures predictive of early response and outcome in high-risk childhood acute lymphoblastic leukemia: A Children's oncology group study on behalf of the Dutch Childhood Oncology Group and the German Cooperative Study Group for childhood acute lymphoblastic leukemia
[作者:Bhojwani, D; Kang, H; Menezes, RX; Yang, W; Sather, H; Moskowitz, NP; Min, DJ; Potter, JW; Harvey, R; Hunger, SP; Seibel, N; Raetz, EA; Pieters, R; Horstmann, MA; Relling, MV; den Boer, ML; Willman, CL; Carroll, WL,期刊:Journal of clinical oncology, 页码:4376-4384 , 文章类型: Article,,卷期:2008年26-27]
- PurposeTo identify children with acute lymphoblastic leukemia (ALL) at initial diagnosis who are at risk for inferior response to therapy by using molecular signatures.Patients and MethodsGene expression profiles were ge...
- Results of the EICESS-92 study: Two randomized trials of Ewing's sarcoma treatment - Cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients
[作者:Paulussen, M; Craft, AW; Lewis, I; Hackshaw, A; Douglas, C; Dunst, J; Schuck, A; Winkelmann, W; Kohler, G; Poremba, C; Zoubek, A; Ladenstein, R; van den Berg, H; Hunold, A; Cassoni, A; Spooner, D; Grimer, R; Whelan, J; McTiernan, A; Jurgens, H,期刊:Journal of clinical oncology, 页码:4385-4393 , 文章类型: Article,,卷期:2008年26-27]
- PurposeThe European Intergroup Cooperative Ewing's Sarcoma Study investigated whether cyclophosphamide has a similar efficacy as ifosfamide in standard-risk (SR) patients and whether the addition of etoposide improves su...
- Phase I study of weekly oxaliplatin in relapsed or refractory pediatric solid malignancies
[作者:Geoerger, B; Doz, F; Gentet, JC; Mayer, M; Landman-Parker, J; Pichon, F; Chastagner, P; Rubie, H; Frappaz, D; Le Bouil, A; Gupta, S; Vassal, G,期刊:Journal of clinical oncology, 页码:4394-4400 , 文章类型: Article,,卷期:2008年26-27]
- PurposeTo explore feasibility, maximum-tolerated dose (MTD), and recommended dose (RD) for phase II studies of weekly oxaliplatin for the treatment of relapsed or refractory pediatric solid malignancies.Patients and Meth...
- Medical care in long-term survivors of childhood cancer: A report from the Childhood Cancer Survivor Study
[作者:Nathan, PC; Greenberg, ML; Ness, KK; Hudson, MM; Mertens, AC; Mahoney, MC; Gurney, JG; Donaldson, SS; Leisenring, WM; Robison, LL; Oeffinger, KC,期刊:Journal of clinical oncology, 页码:4401-4409 , 文章类型: Article,,卷期:2008年26-27]
- PurposeTo evaluate whether childhood cancer survivors receive regular medical care focused on the specific morbidities that can arise from their therapy.Patients and MethodsWe conducted a cross-sectional survey of health...
- Prospective relationships of physical activity with quality of life among colorectal cancer survivors
[作者:Lynch, BM; Cerin, E; Owen, N; Hawkes, AL; Aitken, JF,期刊:Journal of clinical oncology, 页码:4480-4487 , 文章类型: Article,,卷期:2008年26-27]
- PurposePhysical activity can enhance quality of life for cancer survivors. However, few longitudinal studies have examined whether physical activity has a sustained effect on improvements in quality of life. The present ...
- Randomized controlled trial of collaborative care management of depression among low-income patients with cancer
[作者:Ell, K; Xie, B; Quon, B; Quinn, DI; Dwight-Johnson, M; Lee, PJ,期刊:Journal of clinical oncology, 页码:4488-4496 , 文章类型: Article,,卷期:2008年26-27]
- PurposeTo determine the effectiveness of the Alleviating Depression Among Patients With Cancer (ADAPt-C) collaborative care management for major depression or dysthymia.Patients and MethodsStudy patients included 472 low...
|